Chlordiazepoxide Hydrochloride and Clidinium Bromide
- Product NDC
- 70700-185
- 11-digit product format
- 707000185
- Labeler code
- 70700
- Product ID
- 70700-185_ecc2f423-75fd-f54d-def1-8e408ec46575
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Chlordiazepoxide Hydrochloride and Clidinium Bromide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Xiromed, LLC
- Application
- ANDA210579
- Marketing category
- ANDA
- Marketing start
- 2021-04-05
- Marketing end
- 0000-00-00
- Substance
- CHLORDIAZEPOXIDE; CLIDINIUM BROMIDE
- Active strength
- 5 mg/1; 1/1
- Pharmacologic classes
- Benzodiazepine [EPC],Benzodiazepines [CS],Anticholinergic [EPC],Decreased Parasympathetic Acetylcholine Activity [PE],GI Motility Alteration [PE],Digestive/GI System Activity Alteration [PE],Cholinergic Antagonists [MoA]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70700-185-01 | Chlordiazepoxide Hydrochloride and Clidinium Bromide | 100 in 1 BOTTLE | CAPSULE | 100 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70700-185 | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULE [XIROMED, LLC] | 2 | Legacy NDC, 1 package rows | 20210407_3f94758a-afda-52dd-28e1-a10dad250ad8.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70700-185-01 | 70700018501 | 100 CAPSULE in 1 BOTTLE (70700-185-01) | 100 capsule | 2021-04-05 | 0000-00-00 | No | No | Current |